Calderdale and Huddersfield NHS Foundation Trust runs Huddersfield Royal Infirmary, Huddersfield and Calderdale Royal Hospital, Halifax, both in West Yorkshire, England. It became a Foundation Trust in 2006.

During the past decade, Calderdale and Huddersfield NHS Foundation Trust conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Calderdale and Huddersfield NHS Foundation Trust" #1 sponsor was "Hoffmann-La Roche" with 1 trials, followed by "King's College Hospital NHS Trust" with 1 trials sponsored, "Population Health Research Institute" with 1 trials sponsored, "University Hospital Southampton NHS Foundation Trust" with 1 trials sponsored and "University Hospitals of Derby and Burton NHS Foundation Trust" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Calderdale and Huddersfield NHS Foundation Trust" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cardiff and Vale University Health Board" with 1 trials as a collaborator and "Cenduit LLC" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Calderdale and Huddersfield NHS Foundation Trust" are "Atrial Fibrillation" (1 trials), "Breast Cancer" (1 trials), "Colorectal Cancer Stage IV" (1 trials), "Crohn's Disease" (1 trials) and "Estrogen Receptor Positive Breast Cancer" (1 trials). Many other conditions were trialed in "Calderdale and Huddersfield NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Calderdale and Huddersfield NHS Foundation Trust" are "Drug" (3 trials), "Diagnostic Test" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "AZD5363" (1 trials), "Atezolizumab" (1 trials), "Axillary lymph node dissection" (1 trials), "Axillary radiotherapy" (1 trials) and "Breast or chest wall radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Calderdale and Huddersfield NHS Foundation Trust" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Calderdale and Huddersfield NHS Foundation Trust". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Calderdale and Huddersfield NHS Foundation Trust, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Calderdale and Huddersfield NHS Foundation Trust, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".